The World Bank has approved the Ksh 14 billion to Kenya to help the country acquire more Covid-19 vaccines.
The supplementary money under Kenya COVID-19 Health Emergency Response Project will help Kenya procure more Covid-19 vaccines.
Kenya will access the vaccine through COVAX and African Vaccine Acquisition Task Team (AVATT).
The funding will additionally help boost the country’s cold chain storage. Kenya will also establish 25 county vaccine stores, equip 1.117 health facilities with vaccine storage equipment, and strengthen the capacity of 36 sub-county stores.
“This additional financing comes at a critical time when the Government of Kenya is making concerted efforts to contain the rising cases of COVID-19 infections and accelerate the deployment of vaccines to a wider population,” stated World Bank Country Director for Kenya, Keith Hansen.
Nevertheless, profits from the new disbursement will help with other activities including advocacy and communication activities, training for health workers, and vaccine safety surveillance.
It’s the second time the World Bank has financed Kenya for the COVID-19 Health Emergency Response Project. The multi-lateral lender has also contributed Ksh.26.5 billion to Kenya’s COVID-19 response.
The World Bank announced last week it had a Ksh 1.3 trillion war to the chest to help developing countries purchase vaccines during these tough times.
Kenya approved the COVID-19 Health Emergency Response Project last year, and it will run until March 31 2025.